Search

Search Results

• Targeted therapy with Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of solid tumours

  Faustyna Piędel, Agata Agnieszka Rocka, Klaudia Daria Szumna, Dominika Katarzyna Madras, Patryk Piotr Jasielski

  133-139

  2020-03-27
• The role of hemostatic changes in the pathogenesis of diabetic retinopathy

  Nataliya Preys, Ivan Savytskyi

  437-443

  2022-06-30
• The complement system and its role in the treatment of ANCA-associated vasculitis

  Natalia Rybak, Iga Dudek, Jakub Czarnota, Michał Dobrzyński, Tomasz Skubel, Małgorzata Drozd

  1037-1042

  2022-08-24
• Sclerostin - a potential new marker of exercise influence on vascular calcification and mineral and bone disorder in hemodialysed adults

  Agnieszka Turon-Skrzypinska, Grazyna Dutkiewicz, Malgorzata Marchelek-Myśliwiec, Aleksandra Ryl, Artur Uzdzicki, Tomasz Przybylski, Iwona Rotter

  67-74

  2019-12-16
• Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus

  Mirella Czapska, Kamila Babkiewicz, Szczepan Pabis, Katarzyna Skórzyńska-Dziduszko

  335-351

  2018-12-14
• THE ROLE OF MATRIX METALLOPROTEINASE MMP-9, ITS INHIBITOR TIMP-1 AND INTERLEUKINE-1β IN PATHOGENESIS OF TRAUMATIC BRAIN INJURY

  S. V. Ziablitsev, Ya. S. Yuzkiv, S. V. Kolesnikova, S. V. Pischulina

  955-961

  2016-09-30
• Adipose tissue and its proinflammatory properties

  Waldemar Pluta, Aleksandra Radecka, Wioleta Dudzińska, Anna Lubkowska

  138-149

  2020-08-06
• Comparative characteristics of inducible NO synthase inhibitor and nitric oxide donor in endothelial dysfunction correction caused by osteoarthrosis under experimental conditions

  K. S. Orel, I. V. Savitsky, I. V. Miastkivska, L. M. Zaiats

  535-544

  2019-01-31
• Imbalance of vasoconstrictor / vasodilation potential caused by experimental osteoarthritis development

  I. V. Savуtskyі, K. S. Orel, O. S. Levkivska

  411-418

  2018-05-31
• Pathogenetic substantiation of thiotriazoline use on the basis of disorders of proteolysis processes and protease inhibitors under conditions of contact dermatitis and experimental pneumonia

  M. M. Regeda-Furdychko

  584-589

  2019-06-28
• Dynamics of endothelial and inducible synthase nitric oxide in experimental osteoarthritis and its correction

  I. V. Savytskyi, K. S. Orel, I. V. Miastkivska, V. I. Savytskyi, O. S. Levkivska

  902-911

  2018-11-30
• Contemporary strategies in the diagnosis and treatment of juvenile jdiopathic arthritis: imaging techniques and therapeutic advances

  Sandra Czyż, Nina Saracen, Wiktoria Marszał, Karolina Nowak, Wiktoria Mistarz, Oliwia Sysło

  65751

  2025-12-22
• Renal dysfunction in patients with chronic toxic hepatitis and ways of its correction

  O. Kvasnytska, A. Gozhenko

  183-189

  2023-05-31
• Osilodrostat therapy in a 26-year-old patient after ineffective surgical treatment of Cushing Disease: a case report

  Magdalena Kamińska, Adam Strzoda, Agata Juda, Kornelia Rojek, Anna Strzoda, Wojciech Sowiński, Agnieszka Polak

  203-208

  2022-12-02
• Tissue inhibitor of matrix metalloproteinase-1 role in left atrium matrix remodeling in patients with atrial febrillation

  A. V. Goryachiy, A. I. Gozhenko, E. M. Levchenko, V. V. Goryachiy, M. A. Kuznetsova, M. I. Arapu

  953-962

  2017-04-25
• New Pharmacologic Approaches in Hypertension: Baxdrostat and Zilebesiran with Insights from BaxHTN and KARDIA-3 Trials

  Katarzyna Skibicka, Tomasz Skibicki, Weronika Wesołowsla, Jarosław Pietrzak

  65430

  2025-09-21
• Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review

  Katarzyna Maria Krukar, Martyna Pustelniak, Katarzyna Rudnicka, Ilona Sajkiewicz, Nadia Miga-Orczykowska, Ilona Jasiuk, Justyna Wójtowicz, Paulina Lemieszek, Ewa Łukaszewska, Klaudia Kister, Kamil Chrościński, Jakub Laskowski

  55282

  2024-09-24
• Inclisiran - hope in the fight against dyslipidemia

  Paulina Krawiec, Karolina Madej, Izabela Wolanin, Bartłomiej Zielonka, Ilona Kowalczyk, Bartłomiej Stachyra, Marta Wolanin, Cezary Stawikowski, Barbara Dengler, Aleksandra Osińska

  11-18

  2023-05-05
• The corvitini role in the corrections disturbances of proteinase inhibitors system in blood under conditions of the development of experimental bacterial keratitis on the background of experimental bronchial asthma and pneumonia

  B. B. Kravets

  141-145

  2015-10-22
• The process of cancer. Part III. Selected vitamins in cancer. Chemoprevention

  Sylwia Paulina Jopkiewicz

  442-453

  2019-05-28
• Dynamics of C-reactive protein in conditions of substance P block

  O. M. Shevchenko, V. O. Sych

  245-251

  2020-10-30
• Proton pump inhibitor (PPI) administration and Clostridioides difficile infection - is this a real clinical problem? A critical review of the literature

  Aneta Głaz, Kinga Knop, Anna Kochanowska, Damian Wach, Zuzanna Piasecka, Ewelina Wesołek, Beata Kasztelan-Szczerbińska, Barbara Skrzydło-Radomańska

  11-22

  2023-10-16
• Ketoacidosis without significantly hyperglycaemia - is it possible?

  Michał Budzyński, Joanna Pekar, Justyna Magdalena Skolarczyk, Monika Tadla, Katarzyna Skórzyńska-Dziduszko

  201-205

  2017-06-10
• Cell reactions of inflammation focus in carrageenan secondary chronic inflammation on the background of substance P blockade

  O. M. Shevchenko, V. O. Sych

  199-211

  2020-11-27
• Proton pump inhibitors overuse - consequences among patients

  Patrycja Kmiotek, Andrzej Materniak, Barbara Skrzydło-Radomańska

  655-660

  2019-08-12
• Poly ADP-ribose polymerase (PARP) inhibitors - new therapeutic strategies in Acute Myeloid Leukemia: a literature review

  Emilia Nowicka, Michał Obel, Kinga Panuciak, Angelika Mastalerczyk, Kamila Czyżak, Jan Lejman, Karolina Makowska, Wiktor Wiśniewski

  104-109

  2022-12-23
• Порушення показників протеїназо-інгібіторної системи в легенях морських свинок у пізній період формування експериментальної бронхіальної астми = The features of state changes of proteinase-inhibitory system in the lungs of guinea pigs in the later period of experimental bronchial asthma

  M. S. Regeda, M. A. Kolishetska, M. O. Kachmarska, M. L. Zastryzhna

  189-196

  2016-01-30
• Streptozotocin - an antibiotic used to induce diabetes on experimental animals

  Dagna Siedlecka, Wojciech Micał, Ewa Krzewicka-Romaniuk

  906-909

  2020-09-30
• Helicobacter pylori infection and arteriosclerosis

  Tamara Anna Rakszewska, Adam Alzubedi

  503-506

  2019-04-26
• The use of inhibitors of fibrinolysis in the treatment of obstetric hemorrhage due to placenta detachment

  Irina A. Lyoshenko, Oleg O. Tarabrin, Maxim Y. Holubenko, Dmitry G. Havrichenko

  129-137

  2016-01-20
• The Role of Laser Therapy in the Treatment of Diabetic Macular Edema (DME): A Review of Contemporary Methods and Clinical Outcomes

  Anna Wijata, Justyna Dutkiewicz, Zuzanna Adriana Przybyłek-Stępień, Ryszard Bartosiński, Jan Szustak, Michał Wijata, Wiktoria Mączyńska, Maria Kąpa, Bartosz Szepietowski, Jakub Kaźmierczak, Ewelina Rycerz

  58411

  2025-03-03
• Non-vitamin K oral anticoagulant in the prevention and treatment of venous thromboembolism. Why betrixaban is different?

  Łukasz Wołowiec, Daniel Rogowicz, Krystian Kałużny, Anna Kałużna, Walery Zukow

  836-846

  2017-08-31
• Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation

  Anna Rodzajewska, Weronika Kuryło, Katarzyna Szklener

  138-147

  2023-08-08
• The new way of Dabigatran reversal – Idarucizumab

  Erwin Ciechański, Krystian Ciechański, Magda Ciechańska, Jarosław Szponar

  108-112

  2019-02-06
• Clinical significancy of WNT pathway inhibition in various cancers

  Patryk Rogaczewski, Michał Janiak , Kamil Borysewicz, Tadeusz Głos, Navid Ahmadi, Łukasz Szylberg

  183-191

  2022-11-03
• SFas and FasL in etiopathogenesis of autoimmune diseases of the thyroid gland and nodular forms of goiter

  M. I. Sheremet, V. O. Shidlovskyy, Y. V. Girla, N. P. Tkachuk, A. G. Tibirna, V. P. Dorosh

  41-49

  2015-12-23
• Exploring the Role of Tranexamic Acid in Dermatology: A literature Review

  Aleksandra Górska, Natalia Gniaź, Wiktor Grela, Jagoda Niewiadomska, Daria Furtak, Dawid Tulej, Natalia Marko, Alicja Dziedzic, Dominika Marciniuk, Paulina Głogowska

  56921

  2025-01-30
• Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review

  Joanna Szydełko, Michał Litwińczuk, Magdalena Szydełko

  828-851

  2019-09-22
• Akkermansia muciniphila – multifunctional bacteria

  Alicja Wosińska, Dorota Pazik, Inga Łopuszyńska, Katarzyna Kosecka, Patryk Rudziński, Aleksandra Cieślik, Anna Jargieło, Karolina Kosieradzka, Dominik Adamowicz, Justyna Stańczyk

  78-91

  2023-07-25
• How to effectively reverse life-thretening effects of non-vitamin K oral anticoagulants?

  Łukasz Wołowiec, Joanna Banach, Daniel Rogowicz, Magdalena Węglarz, Walery Zukow, Władysław Sinkiewicz

  106-116

  2017-02-02
• Modern Strategies in the Pharmacotherapy of Inflammatory Bowel Diseases – A Literature Review

  Bartłomiej Czarnecki , Wiktor Werenkowicz, Aleksandra Boral, Dominika Kryś, Joanna Brzoza, Julia Koczur, Michał Górski, Wiktoria Pniok, Wojciech Kurkiewicz

  60642

  2025-07-01
• The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis

  Dawid Kościołek, Michał Urbaś, Martyna Kępczyk, Aleksandra Kościołek, Kaja Surowiecka, Jakub Misiak, Miłosz Ojdana, Konrad Szalbot, Mikołaj Tokarski, Natalia Marczak

  200-213

  2024-02-20
• Cefiderocol - a promising new antibiotic for the antibiotic-resistant pathogens of the highest epidemiological priority

  Karol Lorenc Lorenc, Magdalena Kozioł, Alicja Sobek, Mateusz Pawlicki, Anna Łopuszyńska, Zofia Misztal, Marcin Lewicki, Agata Smoleń

  81-88

  2019-05-04
• Alzheimer's disease: classification and diagnosis criteria

  Katarzyna Swakowska, Anna Staniszewska

  22-29

  2021-07-05
• The features of state changes of proteinase- inhibitory system in the lungs of guinea pigs in the early period of experimental bronchial asthma

  M. S. Regeda, M. A. Kolishetska, N. G. Sementsiv, M. L. Baida

  419-426

  2015-11-25
• Cancer Cachexia: Innovations in Pharmacotherapy for Terminal-Stage Patients - Review of the latest reports

  Kinga Witowska, Karolina Sacher, Negar Hosseinnejad; Mikolaj Biskupski; Mariola Turemka, Aneta Mandziuk, Urszula Korotko, Krystyna Zabojska, Aneta Klaudia Wojtas, Aleksandra Cygnarowicz

  56667

  2025-01-02
• The case series of baclofen intoxication

  Michał Kos, Justyna Drankowska, Andrzej Kościuk, Karolina Widłak, Michał Tchórz

  15-19

  2019-08-20
• Asthma: shift some indicators proteinase-inhibitory system in the lungs of guinea pigs and their correction of thiotriazolin.

  M. A. Kolishetska, U. P. Vesklyarova, M. L. Zastryzhna

  328-336

  2017-02-05
• Jak inhibitors in the treatment of alopecia areata - a literature review

  Paulina Krzeszowska, Aleksandra Kujawa, Karolina Krochmal, Wojciech Pisarek, Adrianna Samoraj, Jakub Zajączkowski, Kacper Stępniak, Jan Wilk, Karolina Marrodán-Wojtczak, Radosław Kuźma

  60104

  2025-06-05
• Natriuretic peptide pathways in heart failure in the context of the analysis of the mechanism of action and potential usages of sacubitril/valsartan

  Kamila Babkiewicz-Jahn, Justyna Matuszewska, Adrianna Szymańska, Wiktoria Wilanowska, Izabela Oleksak, Karolina Maliszewska, Natalia Załęska

  50185

  2024-05-14
• PARP inhibitors in the treatment of Pancreatic Cancer - A Review of literature

  Jagoda Niewiadomska, Wiktor Grela, Daria Furtak, Dawid Tulej, Paulina Głogowska, Alicja Dziedzic, Natalia Gniaź, Dominika Marciniuk, Natalia Marko, Aleksandra Górska

  56992

  2025-01-22
• Amanitine poisoning - cases, management, therapy results

  Magdalena Kubicka, Joanna Wilk, Paweł Dębiec, Krystian Cholewa, Magdalena Makarewicz, Adrianna Szymańska

  276-280

  2023-03-01
• The Impact of Immune Checkpoint Inhibitors on Fertility Preservation and Pregnancy Outcomes

  Agata Prokopiuk, Adrianna Tabeau, Agnieszka Pawlik, Patryk Dudek, Klaudia Łuczak, Wiktoria Ulicka, Justyna Pięta, Hanna Sitarek, Joanna Prus, Marcel Chudzikowski

  60024

  2025-05-05
• Viloxazine: A New Non-Stimulant Treatment for Attention-Deficit/Hyperactivity Disorder (ADHD)

  Wiktoria Wilanowska, Anna Greguła, Karol Stachyrak, Dawid Mika, Aleksandra Kłos, Kamila Turek, Maciej Lambach, Mateusz Pawlicki, Aleksandra Mazurek, Bartosz Mazur

  71-85

  2024-02-09
• A patient with an acute traumatic subdural hematoma chronically treated with rivaroxaban – a challenge for neurosurgeons

  Wojciech Czyżewski, Bartłomiej Tyzo, Jakub Litak, Arkadiusz Podkowiński

  357-363

  2017-09-28
• Evaluating the Efficacy and Safety of Baricitinib in Reducing COVID-19 Mortality: A Comprehensive Review of Clinical Evidence and Pharmacological Strategies

  Paulina Kwaśniewska, Patryk Graczyk, Anna Wilewska, Kinga Borowiec, Agnieszka Borowiec, Julia Biernikiewicz, Konstanty Alabrudziński, Milena Biernikiewicz, Bartosz Pomirski, Agata Pomirska

  56441

  2024-12-08
• The processes of apoptosis and telomerase activity in endometrial cells under different morphological conditions

  Z. V. Chumak, N. V. Shapoval

  235-243

  2018-05-31
• Study of changes in proteolytic systems of rats under conditions of experimental chronic prostatitis

  O. Kashtelyan, I. Savytskyi, S. Liulko, Y. Mizevych, V. Sarahan

  312-319

  2022-03-31
• Дослідження фаз клітинного циклу та плоїдності ядерної ДНК клітин печінки статевонезрілих щурів при хронічному токсичному гепатиті та корекції лізиноприлом = Research of cell cycle phases and nuclear DNA ploidy in immature liver cells of rats with chronic toxic hepatitis and lisinopril correction

  N. A. Rikalo, Y. M. Beregovenko

  219-228

  2016-01-30
• Treatment of Fibromyalgia - duloxetine or pregabalin?

  Magdalena Bujak, Natalia Rulewska, Filip Grabowski, Jakub Siemko, Dagmara Neska, Dominika Prystacka-Szar, Justyna Stadler-Szajda, Adrianna Czyżnikiewicz, Wenancjusz Stołowski, Magdalena Waśniowska

  57856

  2025-04-05
• Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)

  Przemysław Żelazny, Joanna Filipczak, Oliwer Sygacz, Sebastian Bróż, Sara Dankiewicz, Aleksandra Swora, Joanna Borowik, Wojciech Brodowski, Piotr Pawłowski, Katarzyna Basta-Arciszewska

  583-588

  2022-09-08
• A PARP inhibitors in the treatment of breast cancer - A Review of literature

  Jagoda Niewiadomska, Borys Bondos, Aleksandra Stępień, Alicja Paluch, Jakub Skrzypek, Aleksandra Niekra, Łukasz Fussek, Robert Kochan, Ewelina Wieczorek, Kacper Lee

  56024

  2024-11-21
• Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review

  Adrian Kruk, Aleksandra Dorosz, Agnieszka Skoczeń, Michał Kulesza, Weronika Wawrzynów, Magdalena Maria Jakubowska, Natalia Rutecka, Błażej Kaczmarek, Martyna Miłoś, Agata Kuśnierz-Gibała

  58442

  2025-03-05
• Extracellular matrix change in patients with various forms of atrial fibrillation

  A. V. Goryachiy, A. I. Gozhenko, E. M. Levchenko, V. V. Goriachyi, M. A. Kuznetsova, M. I. Arapu

  1223-1235

  2017-06-30
• Precision Negative Inotropy: The Rise of Cardiac Myosin Inhibitors in HCM

  Katarzyna Skibicka, Tomasz Skibicki, Weronika Wesołowska, Robert Bujak

  65626

  2025-09-24
• Effect of ras-blockers and no-cycle metabolites on the renal functions of rats exposed to thyroxine injections

  S. I. Dolomatov, T. P. Sataieva

  41-55

  2014-01-12